Drug recall · August 9, 2023
phenylephrine 50 mg added to 0.9% sodium chloride 250mL recall
Why: Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
phenylephrine 50 mg added to 0.9% sodium chloride 250mL, CONCENTRATION = 200mcg/mL, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043. NDC:72196-7039-1
- Lots / codes
Lot: 36-251703, Exp. 8/28/2023; 36-251704, Exp. 8/29/2023
- Quantity
- 472 bags
- Company
- Central Admixture Pharmacy Services, Inc., Phoenix, AZ
- Distribution
- Nationwide in the USA
- Initiated
- July 14, 2023 · Voluntary: Firm initiated
- Classified
- August 1, 2023
- Reported
- August 9, 2023
- Ended
- March 28, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenylephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.